In this free webinar, learn about key strategies that speed upaccelerate monoclonal antibody (mAbs) products and therapies from the clinic to commercial scale-up. These include employing fully integrated end-to-end single-use technologies, a quality-by-design (QbD) approach, modular downstream processes, and scalable process trains. The featured speakers will explore how an established routine, expertise and new technologies can seamlessly take a biologic from benchtop to commercial scale manufacturing.
TORONTO, May 28, 2024 /PRNewswire-PRWeb/ -- In this webinar, the expert speakers will discuss the important role that key technologies and processes play in expediting an early-phase biologics path to the clinic and beyond.
The mammalian cell-based biomanufacturing industry continues to lead the market for biologics. These include monoclonal antibodies (mAbs), fusion proteins, antibody fragments, bispecific and bifunctional antibodies and antibody-drug conjugates (ADCs).
After decades of development, these drugs are proving to be highly efficacious; however, to meet increasing demands, the industry needs robust and flexible production processes and technologies that are also cost-effective while ensuring product quality and consistency. Many of the new generation of mAb-related products require additional process development compared to traditional mAbs.
If drug developers seek to maintain their path to clinic with the speed at which these new modalities are coming through from discovery, they will require strategies that are efficient, scalable, yet straight-forward and transferable. In recent years, fully integrated end-to-end single-use technologies combined with advances in cell line development (CLD) and new purification platforms have transformed manufacturing platforms and processes for early-phase biologics.
Using case studies, the expert speakers will demonstrate how Abzena utilizes Sartorius' technologies while applying a quality-by-design (QbD) approach based on proven science and engineering techniques to establish a de-risked strategy that allows for rapid process development and implementation in a contract development and manufacturing organization (CDMO) setting.
Process changes and improvements can be achieved rapidly for new and existing processes without detrimentally impacting product quality. From defining and testing a scalable process for Phase I to optimizing and characterizing the process for late phase and commercial launch, the speakers will draw on their experience in applying QbD techniques from process design to continual improvements across multiple therapeutic modalities.
Register for this webinar today to learn how to streamline the development and manufacturing of early-phase biologics by applying a quality by-design technique.
In this webinar, attendees will gain insights into:
- How an established routine, expertise and single-use technologies can provide a solid foundation for success in antibody development
- How a modular downstream process can be designed for plug-n-play flexibility while maintaining agility to meet development timelines
- How scalable process trains can seamlessly take a biologic from benchtop to commercial scale manufacturing
- How quality documentation can aid in quality improvements
- How single-use technologies can enhance quick turnover, ease of implementation and time to market
Join Dennis J. Yoon, Senior Director, Manufacturing Science and Technology, Abzena; and Priyanka Gupta, Head of Product Solutions and Marketing, Separations Technology, Sartorius, for the live webinar on Wednesday, June 12, 2024, at 11:30 am EDT (4:30 pm BST/UK).
For more information, or to register for this event, visit Accelerating Early-Phase Biologics to Clinic: Key Technologies and Process Strategies in Mammalian Cell-Based Manufacturing.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/
Media Contact
Soumya Shashikumar, Xtalks, +1 (416) 977-6555 x371, [email protected], https://xtalks.com
SOURCE Honeycomb Worldwide Inc.
Share this article